We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,013

The Highs Celebrating the Ten Best Prescription DrugMedical Device Decisions of 2017
  • Reed Smith LLP
  • USA
  • December 28 2017

Ending the year on a high note is one thing that the blog tries to do - with the top ten drugdevice product liability decisions of the year


California Passes Two Drug Pricing Transparency Laws
  • Quarles & Brady LLP
  • USA
  • November 20 2017

Last month, California Governor Jerry Brown signed two new bills aimed at curtailing rising prescription drug costs, joining other states like


West Virginia Plaintiffs Haunted by Past Excesses
  • Reed Smith LLP
  • USA
  • November 13 2017

We remember how, shortly after the atrocious decision in Johnson & Johnson v. Karl, 647 S.E.2d 899 (W. Va. 2007), rejecting altogether the learned


FTC Holds Public Workshop to Consider If Hatch-Waxman Is Working for Prescription Drug Competition
  • Arent Fox LLP
  • USA
  • November 13 2017

On November 8, 2017, the Federal Trade Commission held a workshop entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply


New Report Says Biosimilars Could Save $54 Billion in Biologics Spending
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • November 7 2017

According to a new report by RAND Corporation, biosimilars could save $54 billion in healthcare spending on biologics over the next ten years


California Passes Drug Transparency Law with Onerous Reporting Requirements for Manufacturers
  • Arent Fox LLP
  • USA
  • October 20 2017

Following in the steps of Maryland and Nevada, California just adopted a comprehensive drug pricing transparency law that will have a significant


CNN Investigates Expanding Use of Nuedexta in Nursing Homes
  • Stark & Stark
  • USA
  • October 16 2017

A recent investigation by CNN brought to light the expanding and allegedly inappropriate use of the prescription drug Nuedexta in nursing homes


New California Law Limits Drug Manufacturer Co-Pay Cards and Other Discounts in California
  • Hogan Lovells
  • USA
  • October 16 2017

In the most recent salvo by states eager to show an effort to contain prescription drug costs, California's governor has signed into law a bill that


FDA Issues Warning About Dietary Supplements Containing Active Drug Ingredients
  • Stark & Stark
  • USA
  • October 11 2017

The FDA has issued a safety alert to consumers involving several dietary supplements including Rhino 7, Papa Zen, Fifty Shades, and Grande X. The


Never Too Late to Celebrate Preemption
  • Dechert LLP
  • USA
  • October 5 2017

Can you recall what you were doing back in March of this year? To be more precise the day before St. Patty's Day and the day after the Ides. No? Well